Health & Biotech · Jan 27, 2026, 7:00 PM EST
Sheba ARC: The Global Innovation ArmSheba Medical Center's ARC (Accelerate, Redesign, Collaborate) Innovation Center operates as a major hospital-based innovation arm coordinating clinic…
Israel Real Economy · 29 stories · Updated Aug 14, 2026
Health & Biotech
Latest in Health & Biotech
29 stories
Lead storyHealth & Biotech · Sep 10, 2026, 5:00 AM EDT
Beilinson Hospital: Clalit's Transplant Leader
Clalit's Petah Tikva tertiary flagship (Rabin Medical Center) and Israel's #1 transplant center. Top-tier in the hospitals Answer Index — everywhere, first nowhere. Not medical advice.
Read →Topics
Deeper coverage tracks inside Health & Biotech
Reference and analysis
Long-form reference entries in Health & Biotech
- The IIA Budget as Industrial Policy
The Israel Innovation Authority's grant programs are the cheapest non-dilutive capital in Israel and the single clearest…
- Reichman and the Private University Question
Reichman University is Israel's only private research university and the closest analog to a Stanford-style entrepreneur…
- Yeda's Copaxone — The Best Academic License in History
The Weizmann Institute's tech transfer arm earned more than $1.5bn in royalties on a single multiple sclerosis drug. The…
- The Technion Pipeline
The Technion is the single largest source of Israeli founder formation. T3 — its tech-transfer arm — and the surrounding…
- Weizmann and the Yeda Model
Yeda — the Weizmann Institute's tech-transfer arm — is the prototype Israeli university commercialisation vehicle. Its l…
- The Israeli Hospital Innovation Engine: Sheba, Hadassah, Ichilov & the Commercial Translation Layer
- Sheba ARC: The Global Innovation Arm and Sheba Medical Center's International Position
Israeli Biotech Companies — The Olam Reference
Articles
Page 2 of 4
Health & Biotech · Mar 30, 2026, 8:00 PM EDT
The Israeli Hospital Innovation Engine: Commercial LayerInside the Israeli hospital innovation architecture — Sheba ARC, Hadasit, Tasmc, Rambam and Soroka innovation arms, the commercial translation pipelin…
Health & Biotech · Jul 5, 2026, 8:13 AM EDT
Compugen: Talpiot-Founded Drug DiscoveryCompugen (Nasdaq: CGEN; TASE: CGEN) — Israeli immuno-oncology and predictive drug-discovery pioneer. Founded 1993 by Eli Mintz, Simchon Faigler, Amir…
Health & Biotech · May 26, 2026, 5:49 AM EDT
Teva: The Post-Allergan Deleveraging CycleTeva paid $40.5 billion for Allergan Generics in 2016 and watched approximately $50 billion in market value evaporate. Eight years and three CEOs late…
Health & Biotech · Jun 9, 2026, 8:20 AM EDT
The Teva ProblemIsrael's one pharmaceutical giant nearly destroyed itself reaching for scale. Its recovery is real — but it is a story about surviving the generics mo…
Health & Biotech · Jun 8, 2026, 1:00 AM EDT
The Maccabi Innovation PipelineMaccabi serves ~2.4 million Israelis and runs the country's largest biobank through KSM. The most commercially accessible HMO partnership platform in…
Health & Biotech · Jul 1, 2026, 2:15 AM EDT
Maccabi Healthcare ServicesThe second-largest of Israel's four statutory health funds, covering roughly a quarter of the population and home to the KSM Research Institute medica…
Health & Biotech · Jul 3, 2026, 2:15 AM EDT
Tofes 17: The Form That Runs Israel's Healthcare EconomyTofes 17 is the authorization form Israel's four health funds issue for external medical services. It is the commercial gate that decides which foreig…
Health & Biotech · Jul 2, 2026, 2:15 AM EDT
Sal HaTziyud (Health Services Basket)The legally defined package of medical services, drugs, and devices that every Israeli resident is entitled to receive under the country's 1995 Nation…